As reported in The Lancet: “Our trial provides the first evidence of a demonstrative spatial repellent protective efficacy in reducing risk of malaria infection in an African setting characterised by high malaria transmission, pyrethroid resistant malaria vectors, and high coverage of insecticide treated nets. Results support spatial repellent products as a beneficial component of malaria prevention.” The SC Johnson Mosquito Shield™ spatial repellent is an easy-to-use product that can help protect a semi-enclosed or enclosed space from mosquitoes without requiring electricity or a flame to work. This repellent is ideal for semi-permanent homes, clinics requiring frequent cleaning, temporary IDP camps and rapid response settings. It has been through trials in Indonesia, Peru, and now Kenya with promising results.
Each year millions of people become infected with malaria. The disease can often be fatal, despite traditional safeguards such as insecticide-treated mosquito nets. As reported in The Lancet, a randomized controlled trial showed that a spatial repellent reduced malaria transmission by one-third in an area of western Kenya. The trial was part of the Advancing Evidence for the Global Implementation of Spatial Repellents (AEGIS) project, funded by global health agency Unitaid and led by Nicole Achee at the University of Notre Dame. “We are elated,” said Achee, who also holds a joint associate professor appointment in the Eck Institute for Global Health at the University of Notre Dame. “Results from the Kenya trial mark a seminal event in decades-long research on spatial repellents in support of public health.” To learn more about the impact of this research and the collaboration that made it possible, read the press release: https://lnkd.in/erD66-ME Eric Ochomo University of Notre Dame - College of Science Photo: SC Johnson